Stay updated on OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s footer revision label has been updated from “v3.5.2” to “v3.5.3,” reflecting an underlying system/version change without changing the displayed study details.SummaryDifference0.0%

- Check19 days agoChange DetectedEnglish-language location labels were added for Hradec Králové Region, Moravian-Silesian Region, Olomouc Region, and Bucharest with corresponding city+region entries, replacing the previous local-language region labels. The revision version was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedLocation name updated from Padua to Padova, Italy, 35128. The old Padua listing was removed and the Padova listing added to reflect the local city name.SummaryDifference0.0%

- Check47 days agoChange DetectedExpanded list of study locations with numerous new sites across multiple countries (Spain, Romania, Italy, France, Portugal, Mexico, Brazil, Czechia, Poland, Belgium, Austria, the United States, and more). Several existing sites changed status (Not yet recruiting, Completed) or were withdrawn/removed.SummaryDifference3%

- Check61 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a release note and does not alter the study details.SummaryDifference0.0%

- Check83 days agoChange DetectedMinor version tag update from Revision: v3.4.1 to v3.4.2 with no visible changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.